TKI biotech lays out plans to raise about $125M in IPO; Hookipa sets terms for upsized $100M IPO
→ San Diego-based Turning Point Therapeutics has laid out terms for its IPO, planning to sell 7.4 million shares at a range of $16 to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
